Citation Impact
Citing Papers
Leishmaniasis
2018 Standout
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial
2017
Clinical aspects of visceral leishmaniasis in HIV infection
2012
Medicinal attributes of 1,2,3-triazoles: Current developments
2017
Diversity‐Oriented Syntheses by Combining CuAAC and Stereoselective INCIC Reactions with Peptides
2017 StandoutNobel
Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease
2014
Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
2016
Works of Raymond Omollo being referenced
Safety and effectiveness of meglumine antimoniate in the treatment of Ethiopian visceral leishmaniasis patients with and without HIV co-infection
2010
Single-dose liposomal amphotericin B (AmBisome®) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
2011
Validation of Two Rapid Diagnostic Tests for Visceral Leishmaniasis in Kenya
2013
Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial
2014
Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study
2010